CN Stock MarketDetailed Quotes

600285 Henan Lingrui Pharmaceutical

Watchlist
  • 24.32
  • -0.08-0.33%
Market Closed Aug 23 15:00 CST
13.79BMarket Cap20.77P/E (TTM)

Henan Lingrui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Henan Lingrui Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
996.96M
--
+9.31%
Net Income
--
222.79M
--
+28.89%
Analyst Rating
Strong Buy

Aug 24, 2024

Henan Lingrui Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.239B--
--2024/FY-- / 3.754B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.239B--
--2024/FY-- / 3.754B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--

Unlock Free Earnings Estimates

Henan Lingrui Pharmaceutical Earnings Reports

  • Henan Lingrui Pharmaceutical Semi-Annual Report 2024

    Aug 12 12:00 ET

  • Summary of Henan Lingrui Pharmaceutical's Half-Year Report in 2024.

    Aug 12 12:00 ET

  • Ling Rui Pharmaceutical's 2024 First Quarter Report

    Apr 25 12:00 ET

  • Summary of Ling Rui Pharmaceutical's 2023 Annual Report

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 24, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg